From Genotype to Phenotype

  • James L. Hargrove
Part of the Modeling Dynamic Systems book series (MDS)


The idea that rates of degradation influence the time course of approach to new, steady-state concentrations applies to mRNAs and enzymes, but the two-compartment model is incomplete. It does not account for the processes by which transcription is activated, which frequently involve the regulation of DNA-binding proteins by ligands or by covalent modification. Also it does not include the processes involved in mRNA processing and transport, or the impact of the completed protein on cellular metabolism. To be useful to the molecular biologist, a simulation tool should be able to describe any intermediate that could potentially affect the outcome of an experiment, and this requires information about each rate of formation, transfer, or elimination (Hargrove, 1993). In the sequential reactions of gene expression, the processing or transfer of each intermediate not only affects the yield, but also introduces a delay that is proportional to the half-time of each step. Many molecular biologists need to make predictions concerning the effects of altered transcription, nuclear mRNA metabolism, and translational or posttransla-tional controls.


Translational Control Molecular Biologist Nucleocytoplasmic Transport Altered Transcription Hyperbolic Curf 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Almagor, H., and K. Paigen. “The chemical kinetics of induced gene expression. Activation of transcription by noncooperative binding of multiple regulatory molecules.” Biochem. 27 (1988): 2094–2102.CrossRefGoogle Scholar
  2. Baxter, J.D., and G.M. Tomkins. “Specific cytoplasmic glucocorticoid hormone receptors in hepatoma tissue culture cells.” Proc. Natl. Acad. Sci. USA 68 (1971): 932–937.CrossRefPubMedCentralPubMedGoogle Scholar
  3. Fersht, A. Enzyme structure and mechanism. New York: W.H. Freeman and Co., 1985.Google Scholar
  4. Hargrove, J.L. “Microcomputer assisted kinetic modeling of mammalian gene expression.” FASEB J. 7 (1993): 1163–1170.PubMedGoogle Scholar
  5. Hargrove, J.L., M. Hulsey, and E.G. Beale. “The kinetics of mammalian gene expression.” BioEssays 13 (1991): 667–674.CrossRefPubMedGoogle Scholar
  6. Hentze, M.W., T.R. Rouault, J.B. Harford, and R.D. Klausner, “Oxidation-reduction and the molecular mechanism of a regulatory RNA-protein interaction.” Science 244 (1989): 357–359.CrossRefPubMedGoogle Scholar
  7. Koshland, D.E., Jr. “Switches, thresholds, and ultrasensitivity.” TIBS 12 (1987): 225–229.Google Scholar
  8. Levitzki, Alexander. In: Receptors: A Quantitative Approach. Menlo Park, Cal.: Benjamin/Cummings Publishing Co., 1984.Google Scholar
  9. Liao, J.C., and J. Delgado. “Advances in metabolic control analysis.” Biotechnol. Prog. 9 (1993): 221–233.CrossRefGoogle Scholar
  10. Manzella, J.M., and P.J. Blackshear. “Regulation of rat ornithine decarboxylase mRNA translation by its 5′-untranslated region.” J. Biol. Chem. 265 (1990): 11817–11822.PubMedGoogle Scholar
  11. Moore, R.E., T.L. Goldsworthy, and H.C. Pitot. “Turnover of 3′-polyadenylate-contain-ing RNA in livers from aged, partially hepatectomized, neonatal, and Morris 5123C hepatoma-bearing rats.” Cancer Res. 40 (1980): 1449–1457.PubMedGoogle Scholar
  12. Mulvihill, E.R., and R.D. Palmiter. “Relationship of nuclear estrogen receptor levels to induction of ovalbumin and conalbumin mRNA in chick oviduct.” J. Biol. Chem. 252 (1977): 2060–2068.PubMedGoogle Scholar
  13. Munro, H.N. “Iron regulation of ferritin gene expression.” J. Cell. Biochem. 44 (1990): 107–115.CrossRefPubMedGoogle Scholar
  14. Palmiter, R.D., P.B. Moore, E.R. Mulvihill, and S. Emtage, “A significant lag in the induction of ovalbumin messenger RNA by steroid hormones: a receptor translocation hypothesis.” Cell 8 (1976): 557–572.CrossRefPubMedGoogle Scholar
  15. Persson, L., I. Horn, and O. Heby. “Regulation of ornithine decarboxylase mRNA translation by polyamines.” J. Biol. Chem. 263 (1988): 3528–3533.PubMedGoogle Scholar
  16. Salter, M., R.G. Knowles, and C.I. Pogson. “Quantification of the importance of individual steps in the control of aromatic amino acid metabolism.” Biochem. J. 234 (1986): 635–647.PubMedCentralPubMedGoogle Scholar
  17. Schimke, R.T. “Control of enzyme levels in mammalian tissues.” Adv. Enzymol. 37 (1973): 135–187.PubMedGoogle Scholar
  18. Strickland, S., and J.N. Loeb. “Obligatory separation of hormone binding and hormone action.” Proc. Nat. Acad. Sci. USA 78 (1981): 1366–1370.CrossRefPubMedCentralPubMedGoogle Scholar
  19. Taylor, P., and P.A. Insel. “Molecular basis of pharmacologic selectivity.” In: Principles of Drug Action, The Basis of Pharmacology, Pratt, W.B., and P. Taylor, eds. New York: Churchill Livingstone, 1990.Google Scholar
  20. Tepperman, H., J. Tepperman, J. Pownall, and A. Branch. “On the response of hepatic glucose 6-phosphate dehydrogenase activity to changes in diet composition and food intake pattern.” Adv. Enzyme Reg. 1 (1963): 121–136.CrossRefGoogle Scholar
  21. Westerhoff, H.V., A.K. Groen, and R.J.A. Wanders. “Modern theories of metabolic control and their application.” Bioscience Reports 4 (1984): 1–22.CrossRefPubMedGoogle Scholar
  22. Yamamoto, K.R., and B. Alberts. “The interaction of estradiol receptor protein with the genome: an argument for the existence of undetected specific sites.” Cell, 4 (1975): 301–310.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • James L. Hargrove
    • 1
  1. 1.Department of Foods and NutritionUniversity of GeorgiaAthensUSA

Personalised recommendations